Clinical-stage biopharma company Reunion Neuroscience has received the FDA’s clearance on its Investigational New Drug (IND) application to begin a Phase 2 study of RE104, a novel serotonergic psychedelic compound aimed at treating postpartum depression (PPD.)
HEI Chief Financial Officer Paul Ito to Become CFO of Hawaiian Electric Company Through Approximately December 31, 2024, Following Planned Retirement of Tayne SekimuraUtility Industry Veteran Scott DeGhetto to Join HEI
https://www.cnbc.com/2023/09/18/salesforce-is-luring-boomerangs-to-reaccelerate-growth.htmlSalesforce has recruited back at least eight executives this year.It held an event for alumni last week at its Dreamforce
Promising exarafenib combination data in NRAS mutant melanoma; intend to select two doses in the fourth quarter of 2023 for further developmentPlan to file KIN-8741 c-MET inhibitor Investigational New Drug application
Ascent Industries Co. (NASDAQ:ACNT) ("Ascent" or the "Company"), an industrials company focused on the production and distribution of industrial tubular products and specialty chemicals, has appointed J. Bryan Kitchen as
https://www.cnbc.com/2023/09/18/uaw-strike-stellantis-could-close-18-facilities-under-deal.htmlStellantis' latest offer to the United Auto Workers could lead to the closure of 18 facilities, sources told CNBC.The
Candidates are invited to explore full- and part-time seasonal opportunities supporting Macy's, Inc.'s omnichannel shopping experience across its portfolio of nameplates including Macy's, Bloomingdale's and
https://www.theverge.com/2023/9/18/23878609/microsoft-windows-panos-panay-leavingPanos Panay, the chief product officer at Microsoft leading Windows development and the company's Surface line, is leaving Microsoft. In an
Advanced Emissions Solutions, Inc. (NASDAQ:ADES) (the "Company" or "ADES"), a producer of activated carbon, and other environmentally efficient carbon products for use in purification, sustainable energy, sustainable